http://investor.neuralstem.com/news/rss The latest news released by Neuralstem, Inc. (CUR) en-us Equisolve Investor Relations Suite http://investor.neuralstem.com/news/detail/230/neuralstem-announces-the-appointment-of-two-new-members-to-the-board-of-directors Mon, 25 Sep 17 16:05:00 -0400 http://investor.neuralstem.com/news/detail/229/neuralstem-announces-issuance-of-two-u-s-patents Thu, 07 Sep 17 07:03:00 -0400 http://investor.neuralstem.com/news/detail/228/neuralstem-reports-second-quarter-2017-fiscal-results-andprovides-clinical-and-business-update Tue, 08 Aug 17 07:30:00 -0400 http://investor.neuralstem.com/news/detail/227/neuralstem-awarded-~1mm-grant-by-nih-to-continue-preclinical-research-into-the-potential-of-nsi-189-for-treatment-of-diabetic-neuropathy Wed, 02 Aug 17 08:30:00 -0400 http://investor.neuralstem.com/news/detail/226/neuralstem-announces-pricing-of-public-offering-of-common-stock-and-warrants Thu, 27 Jul 17 08:30:00 -0400 http://investor.neuralstem.com/news/detail/225/neuralstem-announces-proposed-public-offering-of-common-stock-and-warrants Wed, 26 Jul 17 16:50:00 -0400 http://investor.neuralstem.com/news/detail/224/neuralstem-announces-top-line-phase-2-data-of-nsi-189-for-major-depressive-disorder Tue, 25 Jul 17 08:15:00 -0400 http://investor.neuralstem.com/news/detail/223/neuralstem-added-to-the-russell-microcap-index Mon, 26 Jun 17 08:32:00 -0400 http://investor.neuralstem.com/news/detail/222/neuralstem-reports-last-subject-out-in-phase-2-trial-of-nsi-189-for-major-depressive-disorder Wed, 17 May 17 16:05:00 -0400 http://investor.neuralstem.com/news/detail/221/neuralstem-reports-first-quarter-2017-fiscal-resultsprovides-clinical-and-business-update Wed, 10 May 17 16:05:00 -0400 http://investor.neuralstem.com/news/detail/220/neuralstem-expands-phase-1-safety-trial-of-nsi-566-neural-stem-cells-in-spinal-injury Wed, 12 Apr 17 07:35:00 -0400 http://investor.neuralstem.com/news/detail/219/neuralstem-reports-year-end-2016-fiscal-results-and-business-update Thu, 23 Mar 17 07:35:00 -0400 http://investor.neuralstem.com/news/detail/218/neuralstem-to-present-at-oppenheimer-27th-annual-healthcare-conference-on-march-21 Fri, 17 Mar 17 07:03:00 -0400 http://investor.neuralstem.com/news/detail/217/neuralstem-announces-publication-of-nsi-566-data-in-a-rodent-model-of-traumatic-brain-injury Thu, 09 Mar 17 07:03:00 -0500 http://investor.neuralstem.com/news/detail/216/neuralstem-to-present-at-29th-annual-roth-conference Wed, 08 Mar 17 07:03:00 -0500 http://investor.neuralstem.com/news/detail/215/neuralstem-announces-publication-of-nsi-189-preclinical-data-in-journal-of-cellular-physiology Tue, 28 Feb 17 07:03:00 -0500 http://investor.neuralstem.com/news/detail/214/neuralstem-announces-issuance-of-u-s-patent-covering-nsi-189 Wed, 22 Feb 17 07:03:00 -0500 http://investor.neuralstem.com/news/detail/213/neuralstem-announces-last-subject-enrolled-in-phase-2-trial-with-nsi-189-for-major-depressive-disorder Thu, 16 Feb 17 07:02:00 -0500 http://investor.neuralstem.com/news/detail/212/neuralstem-to-present-at-bio-ceo-investor-conference Mon, 13 Feb 17 06:58:00 -0500 http://investor.neuralstem.com/news/detail/211/neuralstem-announces-a-1-for-13-reverse-stock-split Fri, 06 Jan 17 13:01:00 -0500